These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1324219)

  • 1. Aflatoxin and hepatocellular carcinoma: a useful paradigm for environmentally induced carcinogenesis.
    Kolars JC
    Hepatology; 1992 Sep; 16(3):848-51. PubMed ID: 1324219
    [No Abstract]   [Full Text] [Related]  

  • 2. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
    Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of human aflatoxin exposures and their relationship to liver cancer.
    Groopman JD; Scholl P; Wang JS
    Prog Clin Biol Res; 1996; 395():211-22. PubMed ID: 8895991
    [No Abstract]   [Full Text] [Related]  

  • 4. p53 mutations in nonmalignant human liver: fingerprints of aflatoxins?
    Ozturk M
    Hepatology; 1995 Feb; 21(2):600-1. PubMed ID: 7843737
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
    El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
    J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.
    Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC
    Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma--carcinogenesis updated.
    Yap I
    Singapore Med J; 1995 Dec; 36(6):597-9. PubMed ID: 8781628
    [No Abstract]   [Full Text] [Related]  

  • 8. p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand.
    Hollstein MC; Wild CP; Bleicher F; Chutimataewin S; Harris CC; Srivatanakul P; Montesano R
    Int J Cancer; 1993 Jan; 53(1):51-5. PubMed ID: 8380058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of mutations in the p53 tumor suppressor gene in woodchuck hepatocellular carcinomas associated with hepadnavirus infection and intake of aflatoxin B1.
    Rivkina M; Cote PJ; Robinson WS; Tennant BC; Marion PL
    Carcinogenesis; 1996 Dec; 17(12):2689-94. PubMed ID: 9006107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel adenine adducts, N7-guanine-AFB1 adducts, and p53 mutations in patients with schistosomiasis and aflatoxin exposure.
    Habib SL; Said B; Awad AT; Mostafa MH; Shank RC
    Cancer Detect Prev; 2006; 30(6):491-8. PubMed ID: 17113242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 proteins and aflatoxin b1: the good, the bad, and the ugly.
    Liang TJ
    Hepatology; 1995 Oct; 22(4 Pt 1):1330-2. PubMed ID: 7557889
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of hepatocellular carcinoma according to aetiology.
    Nault JC
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):937-47. PubMed ID: 25260319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Co-inactivation of the p53 and RB genes in human hepato cellular carcinoma].
    Murakami Y
    Nihon Rinsho; 1993 Feb; 51(2):375-9. PubMed ID: 8096551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic variation of p53 mutational profile in nonmalignant human liver.
    Aguilar F; Harris CC; Sun T; Hollstein M; Cerutti P
    Science; 1994 May; 264(5163):1317-9. PubMed ID: 8191284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solving the viral-chemical puzzle of human liver carcinogenesis.
    Harris CC
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):1-2. PubMed ID: 8118377
    [No Abstract]   [Full Text] [Related]  

  • 18. P53 gene of chang-liver cells (Atcc-Ccl13) exposed to aflatoxin B1 (Afb): the effect of lysine on mutation at codon 249 of exon 7.
    Uwaifo O
    Afr J Med Med Sci; 1999; 28(1-2):71-5. PubMed ID: 12953991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [p53 gene mutation in hepatocellular carcinoma].
    Jiang W; Lu Q; Pan G
    Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.